Recent news on Neupogen

The bill that could rock biotech  -  Apr 30, 2007
CNNMoney.comAmgen's blockbuster drugs Epogen and Neupogen, which are used to treat serious side effects from chemotherapy, could both get pressured by generic

Royalty Pharma Acquires a Portion of New York University's Royalty ...  -  May 4, 2007
PR Newswire (press release),...of approximately 80% of Memorial Sloan Kettering's US and international royalty interests in Neupogen(R) and Neulasta(R) for over $400 million.

Blood drive raises awareness  -  May 23, 2007
Folsom Telegraph,Prior to his marrow transplant, he regularly received red blood cells, platelets, and Neupogen shots, which boost white blood cell count.

Cleveland BioLabs Protectan CBLB612 Produces Breakthrough In Bone ...  -  May 22, 2007
Medical News Today (press release),This compares to the current clinical practice of administering a single purified cytokine, such as G-CSF (Neupogen(R), Granocyte(R), Neulasta(R)).

Novel Developments at Neose  -  May 21, 2007
Motley Fool...in excess of $15 billion -- dominated by Johnson & Johnson's (NYSE: JNJ) Procrit and Amgen's (Nasdaq: AMGN) Aranesp, Epogen, Neulasta, and Neupogen.

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Genetic Engineering News (press release),...of approximately 80% of Memorial Sloan Kettering's US and international royalty interests in Neupogen(R) and Neulasta(R) for over $400 million.

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Business Wire (press release),...acquisitions of approximately 80% of Memorial Sloan Kettering’s US and international royalty interests in Neupogen® and Neulasta® for over $400 million.

Red and White Results at Amgen  -  Apr 24, 2007
Motley FoolThe compound names have also grown, as Amgen has been able to expand the patent expiration horizon on its original Neupogen (white blood cells) and Epogen

Amgen earnings meet forecasts  -  Apr 23, 2007
CNNMoney.comCombined sales for Neulasta and Neupogen, drugs used with therapy to fight infection, jumped 14 percent to just more than $ 1 billion.

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 ...  -  Apr 23, 2007
Genetic Engineering News (press release),Combined sales of Neulasta and NEUPOGEN in the United States were $777 million in the first quarter of 2007 versus $688 million in the first quarter of 2006

When vegging out plants a seed of hope  -  Apr 15, 2007
Ventura County Star (subscription),To increase the number of blood-forming cells in his bloodstream, Hardy had undergone injections of the Amgen drug Neupogen for five days before the

Facing Reality on Follow-On Biologics  -  Apr 23, 2007
American Enterprise Institute,As their focus moves to a newer generation of biologics such as Epogen and Neupogen (which treat the side effects of kidney failure and cancer chemotherapy,

Bone marrow donation: What to expect when you donate  -  Apr 6, 2007
MayoClinic.comThe medication, filgrastim (Neupogen), is typically given as an injection once a day for four or five days before your bone marrow stem cell donation.

Amgen earnings on the rise as Aranesp sales still grow  -  Apr 24, 2007
Pharma Times (subscription),As for its other drugs, Neupogen (filgrastim) and Neulasta (pegfilgrastim), used to boost white blood cells in patients on chemotherapy, saw combined sales

Cleveland BioLabs Protectan CBLB612 Demonstrates Efficacy In ...  -  Apr 21, 2007
Medical News Today (press release),...of hematopoietic stem cells in blood is multiple injections of granulocyte-colony stimulating factor or G-CSF (Neupogen(R), Granocyte(R), Neulasta(R)).

Billion dollar babies—biotech drugs as blockbusters  -  Apr 3, 2007
Nature.com (subscription),The FDA approved the first biotech blockbusters, Epogen and Neupogen (filgrastim, Amgen's recombinant granulocyte-colony stimulating factor prescribed for

Missouri and monitor its rejecting settlement longer.  -  Apr 15, 2007
LIVE-Wintersport.com,Complications of droves because country to length and Neupogen questions. Canadian series safety measures public education Restasis virus with whites.

CoGenesys Expands Clinical Programs With Initiation Of Phase 1-2a ...  -  Mar 29, 2007
Medical News Today (press release),Three products have been approved for marketing in the United States: Amgen's Neupogen(R) and Neulasta(R), and Schering AG's Leukine(R).

Sophomore regains sensation in legs, lower abdomen after multiple ...  -  Mar 27, 2007
Ball State Daily News,Snell underwent treatment in which Neupogen, an amino acid that stimulates red blood cell growth, was injected into his blood stream.

Tuesday Newspaper Review - Irish Business News and International ...  -  Apr 17, 2007
FinFacts Ireland,To this day, Amgen still largely lives off Epogen, first approved in 1989, and Neupogen, approved in 1991 to prevent infection in patients receiving

Lexicon Genetics Elects Kathleen Wiltsey to Board of Directors  -  Mar 12, 2007
Drug Newswire (press release),Ms. Wiltsey also participated in engineering Amgen's $84 million R&D limited partnership financing of NEUPOGEN(R), Amgen's second product, and in European

Dueling Fools: Elan  -  Mar 15, 2007
Motley FoolI saw Amgen (Nasdaq: AMGN) blaze through the 1990s on the heels of just two blockbuster drugs in Neupogen and Epogen. And maybe having a diversified drug

Drugs to boost immune system during chemo may hike risks  -  Mar 5, 2007
Jackson Clarion Ledger,Growth factors such as G-CSF, known by the trade name Neupogen, and GM-CSF boost the patient's production of white blood cells.

Florida man sentenced for $42 million Lipitor fraud  -  Mar 5, 2007
Times Record News,Albers admitted that he sold counterfeit and misbranded Neupogen to a California firm in September 2001, despite warnings and notices from the Food and Drug

For Booming Biotech Firms, A New Threat: Generics  -  Mar 13, 2007
Wall Street Journal (subscription),In 2005, Barr announced a deal to license Pliva's version of a white-blood-cell booster made by Amgen called Neupogen. It was a risky move,

Biotechnology and the Divine Right of Kings  -  Mar 15, 2007
Agoravox,...copycat versions of some of the costliest drugs sold in America: biologics like Amgen’s Epogen and Neupogen, and Genentech’s human growth hormone.

The Risk Problem  -  Mar 12, 2007
Forbes,Still, the company has a strong product line, including Neupogen and Enbrel, plus some promising drugs in the pipeline. Earnings should grow at a 12%-to-15%

Category 5 Stocks  -  Mar 8, 2007
Motley FoolDelve into Amgen (Nasdaq: AMGN) as its Neupogen and Epogen drugs first hit the market or Southwest Airlines as it reinvented air travel with its low-cost,

Transplant offers second chance at life  -  Mar 5, 2007
Radford News Journal,Well, Kostmann's Syndrome may have never had a more worthy adversary than now-seven-year-old Henry Moore, who, through twice daily injections of Neupogen

Dose-Intensive Chemotherapy with Stem Cell and Neupogen® Support ...  -  Feb 5, 2007
Cancer Consultants (press release),A randomized phase III study that intensified doses of ICE (ifosfamide, carboplatin, and etoposide) administered with autologous stem cell and Neupogen

Amgen Drugs Linked to Leukemia  -  Feb 7, 2007
Red Herring,However, many analysts feel that negative reactions about the prospects for Neupogen and Neulasta are too alarmist. They point out that, while white blood

Amgen infection drug tied to higher cancer risk  -  Feb 7, 2007
Los Angeles Times,Amgen Inc.'s Neupogen, used to combat infections in patients undergoing chemotherapy, may increase the risk of blood cancers in breast cancer patients,

Generic biotech drugs urged  -  Jan 28, 2007
Baltimore Sun,Ockuly credits the biotech drug, Neupogen, with helping save her life four years ago, but wishes there had been a generic alternative available for less

Potential Risk Detected in Amgen Drug  -  Feb 7, 2007
Los Angeles Business Journal (subscription),Columbia University researchers said older breast cancer patients who took the growth factor Neupogen had a 2 percent chance of developing acute myeloid

Risk Detected in Amgen Drug  -  Feb 7, 2007
Los Angeles Business Journal (subscription),Neupogen was found by Columbia University researcher to elevate the risk of developing a secondary cancer called acute myeloid leukemia in breast cancer

Increased Risk for Amgen Drug  -  Feb 7, 2007
Los Angeles Business Journal (subscription),Neupogen was found by researchers from Columbia University to elevate the risk of developing acute myeloid leukemia or myelodysplastic syndrome in breast

Growth Factors May Increase Risk of AML and MDS in Post-menopausal ...  -  Feb 15, 2007
Cancer Consultants (press release),One group of patients also received growth factors Neupogen® (filgrastim) or Leukine® (sargramostim), and the other group did not receive growth factors.

Growth Factors May Increase Risk of Secondary AML and MDS in Post ...  -  Feb 9, 2007
Cancer Consultants (press release),The patients had stage I-III breast cancer with positive lymph nodes and had received adjuvant chemotherapy with or without Neupogen or Leukine.

Risk still low on drugs to aid immunity  -  Feb 7, 2007
Chicago Tribune,But for the women who received growth factors (mainly Neupogen), the risk of getting leukemia was twice as great as for the others.

Dose-intensive Chemotherapy Improves Survival for Patients with ...  -  Feb 2, 2007
Cancer Consultants (press release),One group of patients in this trial was treated with intensified doses of ICE in addition to Neupogen and autologous stem cell transplant, and the other

Aranesp Data Eclipse Amgen's Fourth-Quarter Revenue Growth  -  Jan 26, 2007
BioWorld Online,31, driven by growth in the company's top-selling drugs, including Aranesp, Neulasta, Neupogen and Enbrel. Full-year revenues reached $14.3 billion.

Amgen Drug Increases Leukemia Risk for Some Patients  -  Feb 7, 2007
San Fernando Valley Business Journal Online (subscription),The study found that almost 2 percent of patients taking Amgen’s Neupogen had an elevated risk of developing acute myeloid leukemia or myelodysplastic

Immunity Boosters Linked to Leukemia  -  Feb 6, 2007
WebMDBut the drugs, G-CSF (such as Neupogen) and GM-CSF (such as Leukine), may themselves cause rare cases of leukemia, find Columbia University researcher Dawn

Business Intelligence Provider Hoover’s Releases Latest Edition of ...  -  Feb 11, 2007
Newswire Today (press release),The numbers were supported by strong sales of anti-anemia drugs Aranesp and EPOGEN, as well as Neulasta and NEUPOGEN, which boost white blood cells in

Dole supports leafy greens marketing pact  -  Feb 7, 2007
Ventura County Star (subscription),Thousand Oaks-based Amgen Inc. makes two of these drugs, Neupogen and Neulasta. The study found that risk for developing the blood conditions was very small

MEDICAL BILLER SENTENCED TO 10 YEARS IMPRISONMENT FOR MEDICARE ...  -  Feb 6, 2007
Media Newswire (press release),The clinic fraudulently billed Medicare for dosages of expensive HIV medications, including Neupogen, Procrit, Acthar, and Fuzeon.

US Attorney's Office cracks down on healthcare fraud  -  Feb 3, 2007
Miami Herald,The patients were HIV positive, but the clinic fraudulently billed Medicare for dosages of expensive HIV medications, including Neupogen, Procrit,

Prison, indictments in South Florida healthcare frauds  -  Feb 1, 2007
Miami Herald,The patients were HIV positive, but the clinic fraudulently billed Medicare for dosages of expensive HIV medications, including Neupogen, Procrit, Acthar,

Brain study offers clues into why humans do good  -  Jan 30, 2007
Asbury Park Press,While G-CSF — known by the trade names Neupogen, Neulasta and Granocyte — had a strong effect in mice, early research in cancer patients treated with G-CSF

Sprycel® Superior to High-Dose Gleevec for Gleevec-Resistant CML  -  18 Jan 2007
Cancer Consultants (press release),Another study suggested that the main side effect of Sprycel was cytopenias that could be corrected by the administration of Neupogen® (filgrastim) or

Cancer therapy may weaken bones  -  Jan 12, 2007
United Press International...animal bone density after an eight-day course of treatment with the growth factor, marketed under the trade names of Neupogen, Neulasta and Granocyte.

Continence program for women  -  Jan 16, 2007
Belleville News-Democrat,G-CSF is known by the trade names Neupogen, Neulasta and Granocyte. St. Louis Children's Hospital has jumped from 10th to 7th in the latest rankings of the

Researchers Urge Monitoring Of Bone Health During Chemotherapy  -  Jan 15, 2007
Medical News Today (press release),G-CSF is known by the trade names Neupogen, Neulasta and Granocyte. Clinical use of G-CSF has recently increased because by speeding blood cell regrowth it

Cleveland BioLabs Protectans Technology Yields Stem Cell Research ...  -  Jan 11, 2007
Medical News Today (press release),...or mobilized peripheral blood harvesting, is an injection of granulocyte-colony stimulating factor or G-CSF (Neupogen(R), Granocyte(R), Neulasta(R)).

Cleveland Biolabs Stock Moves On Stem Cell Report  -  Jan 10, 2007
Cleveland Leader,...marrow or mobilized peripheral blood harvesting, is an injection of granulocyte-colony stimulating factor or G-CSF (Neupogen®, Granocyte®, Neulasta®).

Pharma Sector: Few Newsmakers Of The Week - Schwarz Pharma ...  -  Jan 6, 2007
Trading Markets,Amgen's Neupogen and Neulasta and Schering AG's Leukine are the only three products approved for marketing in the United States for decreasing the incidence

Krisztina Zsebo, Ph.D. Named Venture Partner at Enterprise Partners  -  Jan 5, 2007
PR Newswire (press release),She spent eight years at Amgen in research and product development where she worked on a number of successful products, including EPOGEN(R) and NEUPOGEN(R),

CoGenesys Files To Begin Clinical Trials Of Neugranin For The ...  -  Jan 5, 2007
Medical News Today (press release),Three products have been approved for marketing in the United States: Amgen's Neupogen(R) and Neulasta(R), and Schering AG's Leukine(R).

CoGenesys Files to Begin Clinical Trials of Neugranin for the ...  -  Jan 4, 2007
PipelineReview.com (press release),Three products have been approved for marketing in the United States: Amgen's Neupogen® and Neulasta®, and Schering AG's Leukine®.

The ones HIV left in limbo  -  Jan 2, 2007
Los Angeles Times,Now his salvage therapy regimen reads like a pharmaceutical catalog: Neupogen (three injections a week to boost his white blood cell count);

A winning move, off the field  -  Dec 26, 2006
NorthJersey.com,1, Marcoux had to get shots of Neupogen twice a day for five days. The drug stimulates the growth of the blood stem cells in the bloodstream.

Research and Markets: Gain an Insight into the Financial ...  -  Dec 20, 2006
PharmaLive.com (press release),Neulasta (pegfilgrastim) is a sustained-duration formulation of Neupogen (filgrastim) formed by the addition of polyethylene glycol to granulocyte colony

A winning move, off the field  -  26 Dec 2006
NorthJersey.com,1, Marcoux had to get shots of Neupogen twice a day for five days. The drug stimulates the growth of the blood stem cells in the bloodstream.

Research and Markets: Gain an Insight into the Financial ...  -  Dec 20, 2006
PharmaLive.com (press release),Neulasta (pegfilgrastim) is a sustained-duration formulation of Neupogen (filgrastim) formed by the addition of polyethylene glycol to granulocyte colony

Island Life  -  Dec 8, 2006
Richmond News,...tests, hospitalization, medication and such but it doesn't cover supportive medication such as anti-nausea medication at $20 a pill or Neupogen to make

IAPO biosimilars paper gives wrong impression, says EGA  -  Dec 8, 2006
Pharma Times (subscription),...branded versions of erythropoietin (Epogen, Procrit) and granulocyte-colony stimulating factor (fligrastim, Neupogen) now under threat from biosimilars.

Zacks Analyst Blog Highlights: Techwell, Sallie Mae, Amgen and ...  -  Dec 6, 2006
Business Wire (press release),The company’s key products are Epogen/Aranesp (anemia), Neupogen/Neulasta (neutropenia), and Enbrel (inflammatory disease). We are optimistic about these

PDL BioPharma Announces Participation at Upcoming Lazard Investor ...  -  Nov 27, 2006
Financial News USA (press release),...doctors to use the anemia treatment Aranesp when they use Neupogen or Neulasta, two Amgen drugs used to prevent infections in chemotherapy patients.

Concurrent Chemotherapy, Twice-Daily Radiation and Consolidation ...  -  Nov 27, 2006
Cancer Consultants (press release),Side effects of this regimen could probably be decreased with the use of Neupogen® or Neulasta®. Reference: Saito H, Takada Y, Ichinose Y, et al.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional